ASSOCIATION OF CLINICAL RESEARCH O… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2002

Legal Domicile

Principal Officer

DOUG PEDDICORD

Phone

2024649340

Tax Period

2024-01-01 to 2024-12-31

ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS, founded in 2002, is a community nonprofit in the Community Improvement sector that reported $2.3M in total revenue in fiscal year 2024. Revenue decreased 6% compared to the prior year.

Mission

ACRO AND ITS MEMBERS ADVOCATE ON A GLOBAL BASIS FOR SAFE, ETHICAL, HIGH-QUALITY MEDICAL RESEARCH SO PATIENTS CAN BENEFIT FROM THE DEVELOPMENT OF NEW TREATMENTS AND THERAPIES.

Program Service Accomplishments

Program 1

THE ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS (ACRO) REPRESENTS THE WORLD'S LEADING CLINICAL RESEARCH ORGANIZATIONS AND CLINICAL TECHNOLOGY COMPANIES. ACRO'S MEMBERS PROVIDE SPECIALIZED SERVICES THAT ARE INTEGRAL TO THE DEVELOPMENT OF DRUGS, BIOLOGICS, AND MEDICAL DEVICES. ACRO ADVANCES CLINICAL OUTSOURCING TO IMPROVE THE QUALITY, EFFICIENCY, AND SAFETY OF BIOMEDICAL RESEARCH. ACRO'S PRIORITIES IN 2024 INCLUDED: 1. A US FOCUS ON REGULATORY ADVOCACY, SPECIFICALLY REPRESENTING CLINICAL RESEARCH AND CLINICAL TECHNOLOGY COMPANIES IN POLICY DISCUSSIONS WITH THE FDA. (CONTINUED IN SCHEDULE O) 2. EU ADVOCACY FOCUSED ON REPRESENTING THE INDUSTRY IN POLICY DISCUSSIONS WITH THE EUROPEAN COMMISSION, THE EUROPEAN MEDICINES AGENCY, AND UK AND OTHER EU MEMBER STATE REGULATORY BODIES.3. REPRESENTING MEMBER COMPANIES TO OTHER REGULATORS AND INDUSTRY STAKEHOLDERS SUCH AS CUSTOMERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $2,162,500

Investment Income $151,261

Other Revenue $0

TOTAL REVENUE $2,313,761

Expense Breakdown

Grants Paid $210,000

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $2,227,532

TOTAL EXPENSES $2,437,532

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,313,761	$2,469,015	-0.1%
Expenses	$2,437,532	$2,091,418	+0.2%
Net Income	$-123,771	$377,597	-1.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PEYTON HOWELL	CHAIR	1.00	Officer Director	$0	$0	$0
CYNTHIA VERST	PAST CHAIR	1.00	Officer Director	$0	$0	$0
JIM REILLY	VICE-CHAIR	1.00	Officer Director	$0	$0	$0
MIKE CROWLEY	SECRETARY	1.00	Officer Director	$0	$0	$0
ARI FELDMAN	TREASURER	1.00	Officer Director	$0	$0	$0
GREG LICHOLAI	BOARD MEMBER	1.00	Director	$0	$0	$0
LISA MONEYMAKER	BOARD MEMBER	1.00	Director	$0	$0	$0
JOSEPH SCHMIDT	BOARD MEMBER (Q1-Q3 2024)	1.00	Director	$0	$0	$0
KAREN KAUCIC	BOARD MEMBER	1.00	Director	$0	$0	$0
SEEMA VERMA	BOARD MEMBER	1.00	Director	$0	$0	$0
CATHERINE GREGOR	BOARD MEMBER	1.00	Director	$0	$0	$0
GADI SAARONY	BOARD MEMBER	1.00	Director	$0	$0	$0
JIM CORRIGAN	BOARD MEMBER	1.00	Director	$0	$0	$0
CASSANDRA KENNEDY	BOARD MEMBER	1.00	Director	$0	$0	$0
DOUGLAS PEDDICORD	EXECUTIVE DIRECTOR	30.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,313,761	$2,437,532	$3,293,943	$-123,771
2023	$2,469,015	$2,091,418	$3,426,449	$377,597
2022	$2,348,771	$1,983,993	$2,990,221	$364,778
2021	$2,241,906	$1,872,014	$2,656,292	$369,892
2020	$2,144,736	$1,688,132	$2,239,714	$456,604
2019	$1,956,421	$1,598,172	$1,793,332	$358,249
2018	$1,468,752	$1,331,211	$1,453,590	$137,541

ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS